Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Symptomatic relief in dyspnoea].

Bodil Abild Jespersen1, Annemarie Salomonsen, Torben Riis Rasmussen

  • 1Arhus Sygehus, Arhus Universitetshospital, Det Palliative Team, Onkologisk Afdeling. bajen@as.aaa.dk

Ugeskrift for Laeger
|November 22, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multidisciplinary team meetings for lung cancer in the Nordic countries: results from a Nordic survey.

Acta oncologica (Stockholm, Sweden)·2026
Same author

Corrigendum to 'Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III Lung Cancer After Completion of Curative treatment (SUPE_R): A Randomized Controlled Trial' [Journal of Thoracic Oncology Volume 20 Issue 8 (2025) 1086-1097].

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

[Multidisciplinary team conferences].

Ugeskrift for laeger·2026
Same author

Current opinions on lung cancer screening in the Nordic countries: A survey-based study.

Journal of cancer policy·2026
Same author

Diagnostic Accuracy of [<sup>18</sup>F]FDG PET/CT versus CT for NSCLC Surveillance: Secondary Analysis of a Randomized Clinical Trial.

Clinical lung cancer·2025
Same author

Pulmonary nodules in Denmark: occurrence, resource use, and risk of lung cancer and death.

Acta oncologica (Stockholm, Sweden)·2025
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Breathlessness, a distressing symptom in advanced illnesses like cancer and heart failure, requires a thorough assessment. Management involves identifying reversible causes and employing multidisciplinary, drug-based, and non-pharmacological strategies for relief.

Area of Science:

  • Palliative care and symptom management in advanced progressive illnesses.
  • Respiratory and cardiovascular symptomology in chronic diseases.

Context:

  • Breathlessness (dyspnoea) is a prevalent and distressing symptom in patients with cancer, cardiac failure, chronic obstructive pulmonary disease, and pulmonary fibrosis.
  • The symptom significantly impacts both patients and their caregivers, necessitating effective management strategies.

Purpose:

  • To outline the assessment and management of breathlessness in advanced progressive illnesses.
  • To highlight the importance of identifying reversible causes and exploring various treatment options.

Summary:

  • Effective breathlessness management begins with a comprehensive history and physical examination.
  • A multidisciplinary approach integrating non-pharmacological interventions and pharmacotherapy is crucial for symptomatic relief.

Related Experiment Videos

  • Pharmacological treatments become increasingly predominant as the illness progresses towards its terminal phase.

    • Impact:

    • Provides a framework for healthcare professionals to manage distressing breathlessness in complex patient populations.
    • Emphasizes a holistic and individualized approach to improve patient quality of life and caregiver support.
    • Informs clinical practice regarding the timely and appropriate use of interventions for dyspnoea relief.